GSH or palmitate preserves mitochondrial energetic/redox balance, preventing mechanical dysfunction in metabolically challenged myocytes/hearts from type 2 diabetic mice.
GSH or palmitate preserves mitochondrial energetic/redox balance, preventing mechanical dysfunction in metabolically challenged myocytes/hearts from type 2 diabetic mice.
复制标题
GSH 或棕榈酸酯可保持线粒体能量/氧化还原平衡,防止 2 型糖尿病小鼠代谢受损的肌细胞/心脏发生机械功能障碍
作者:
Tocchetti CG;Caceres V;Stanley BA;Xie C;Shi S;Watson WH;O'Rourke B;Spadari-Bratfisch RC;Cortassa S;Akar FG;Paolocci N;Aon MA
In type 2 diabetes, hyperglycemia and increased sympathetic drive may alter mitochondria energetic/redox properties, decreasing the organelle’s functionality. These perturbations may prompt or sustain basal low-cardiac performance and limited exercise capacity. Yet the precise steps involved in this mitochondrial failure remain elusive. Here, we have identified dysfunctional mitochondrial respiration with substrates of complex I, II, and IV and lowered thioredoxin-2/glutathione (GSH) pools as the main processes accounting for impaired state 4→3 energetic transition shown by mitochondria from hearts of type 2 diabetic db/db mice upon challenge with high glucose (HG) and the β-agonist isoproterenol (ISO). By mimicking clinically relevant conditions in type 2 diabetic patients, this regimen triggers a major overflow of reactive oxygen species (ROS) from mitochondria that directly perturbs cardiac electro-contraction coupling, ultimately leading to heart dysfunction. Exogenous GSH or, even more so, the fatty acid palmitate rescues basal and β-stimulated function in db/db myocyte/heart preparations exposed to HG/ISO. This occurs because both interventions provide the reducing equivalents necessary to counter mitochondrial ROS outburst and energetic failure. Thus, in the presence of poor glycemic control, the diabetic patient’s inability to cope with increased cardiac work demand largely stems from mitochondrial redox/energetic disarrangements that mutually influence each other, leading to myocyte or whole-heart mechanical dysfunction.
登录
查看更多内容
DOI:
10.1016/j.biocel.2009.02.016
发表时间:
2009-10
影响因子:
4
作者:
Aon, M. A.;Cortassa, S.;Akar, F. G.;Brown, D. A.;Zhou, L.;O'Rourke, B.
通讯作者:
O'Rourke, B.
影响因子:
15.9
作者:
Anderson, Ethan J.;Lustig, Mary E.;Neufer, P. Darrell
通讯作者:
Neufer, P. Darrell
DOI:
10.1152/ajpheart.01264.2008
发表时间:
2009-05-01
影响因子:
4.8
作者:
Boardman, Neoma;Hafstad, Anne D.;Aasum, Ellen
通讯作者:
Aasum, Ellen
影响因子:
4.8
作者:
Aon, Miguel A.;Cortassa, Sonia;O'Rourke, Brian
通讯作者:
O'Rourke, Brian
影响因子:
3.4
作者:
Cortassa, S;Aon, MA;O'Rourke, B
通讯作者:
O'Rourke, B